Glenmark Pharmaceuticals Limited has announced its participation schedule for several Analyst and Institutional Investor meetings and conferences. These events are set to take place in Mumbai. The company will attend the Systematix India Annual Conference on February 9th, 2026, followed by Axis Capital's Flagship India Conference on February 11th, 2026. Further engagements include Kotak Securities India Flagship Conference on February 25th, 2026, and the Investec India Promoter & Founder Conference 2026 on March 9th, 2026. All meetings are scheduled as physical events and will include both group and one-on-one sessions. Glenmark Pharmaceuticals has stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. The schedule is subject to change based on unforeseen circumstances.
